Recursive Partitioning as an Approach to Selection of Immune Markers for Tumor Diagnosis

Clinical Cancer Research

Volumn 9, Issue 14, 2003, Pages 5120-5126

  Koziol, James A ^a   Zhang, Jian Ying ^a,b   Casiano, Carlos A ^c   Peng, Xuan Xian ^d   Shi, Fu Dong ^a   Feng, Anne C ^a   Chan, Edward K L ^a,e   Tan, Eng M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS AT EL PASO   (United States)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d XIAMEN UNIVERSITY   (China)

^e UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CYCLIN B1; MYC PROTEIN; PROTEIN IMP1; PROTEIN KOC; PROTEIN P53; PROTEIN P62; SURVIVIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

ANTIBODIES, NEOPLASM; AUTOANTIBODIES; CASE-CONTROL STUDIES; COHORT STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 0242610432     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Crawford, L. V., Pim, D. C., and Bulbrook, R. D. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int. J. Cancer, 30: 403-408, 1982.
2. Soussi, T. p53 antibodies in the sera of patients with various types of cancer. A review. Cancer Res., 60: 1777-1788, 2000.
3. Tan, E. M. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J. Clin. Investig., 108: 1411-1415, 2001.
4. Zhang, J. Y., Chan, E. K., Peng, X. X., Lu, M., Wang, X., Mueller, F., and Tan, E. M. Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies. Clin. Immunol., 100: 149-156, 2001.
5. Zhang, J. Y., Chan, E. K. L., Peng, X. X., and Tan, E. M. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J. Exp. Med., 189: 1101-1110, 1999.
6. Mueller-Pillasch, F., Lacher, U., Wallrapp, C., Micha, A., Zimmerhackl, F., Hameister, H., Varga, G., Friess, H., Buchler, M., Beger, H. G., Vila, M. R., Adler, G., and Gress, T. M. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene, 14: 2729-2733, 1997.
7. Nielsen, J., Christiansen, J., Lykke-Andersen, J., Johnsen, A. H., Wewer, U. M., and Nielsen, F. C. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol. Cell. Biol., 19: 1262-1270, 1999.
8. Covini, G., Chan, E. K., Nishioka, M., Morshed, S. A., Reed, S. I., and Tan, E. M. Immune response to cyclin B1 in hepatocellular carcinoma. Hepatology, 25: 75-80, 1997.
9. Breiman, L., Friedman, J. H., Olshen, R. A., and Stone, C. J. Classification and Regression Trees. Wadsworth, Monterey, CA, 1984.
10. Province, M. A., Shannon, W. D., and Rao, D. C. Classification methods for confronting heterogeneity. Adv. Genetics, 42: 273-286, 2001.
11. Zhang, H., and Singer, B. Recursive Partitioning in the Health Sciences. Springer, New York, 1999.
12. Atkinson, E. J., and Therneau, T. M. An introduction to recursive partitioning using the RPART routines. Technical report, Mayo Clinic Section of Biostatistics, 2000.
13. Venables, W. N., and Ripley, B. D. Modern Applied Statistics with S-PLUS, 3rd Ed., pp. 303-327, Springer, New York, 1999.
14. Doyle, G. A., Bourdeaux-Heller, J. M., Coulthard, S., Meisner, L. F., and Ross, J. Amplification in human breast cancer of a gene encoding a c-myc mRNA binding protein. Cancer Res., 60: 2756-2759, 2000.
15. Kao, H., Marto, J. A., Hoffmann, T. K., Shabanowitz, J., Finkelstein, S. D., Whiteside, T. L., Hunt, D. F., and Finn, O. J. Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells. J. Exp. Med., 194: 1313-1323, 2001.
16. Rohayem, J., Diestelkoetter, P., Weigle, B., Oehmichen, A., Schmitz, M., Mehlhorn, J., Conrad, K., and Rieber, E. P. Antibody to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. Cancer Res., 60: 1815-1817, 2000.
17. Zhang, J. Y., Casiano, C. A., Peng, X. X., Koziol, J. A., Chan, E. K. L., and Tan, E. M. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol. Biomark. Prev., 12: 136-143, 2003.
18. Dillman, R. O., and Koziol, J. A. Statistical approach to immunosuppression classification using lymphocyte surface markers and functional assays. Cancer Res., 43: 417-421, 1983.
19. Zhang, H., Yu, C. Y., Singer, B., and Xiong, M. Recursive partitioning for tumor classification with gene expression microarray data. Proc. Natl. Acad. Sci. USA, 98: 6730-6735, 2001.
20. Zhang, H., Yu, C. Y., and Singer, B. Cell and tumor classification using gene expression data: Construction of forests. Proc. Natl. Acad. Sci. USA, 100: 4168-4172, 2003.
21. Cooper, J. S., Berkey, B., Marcial, V., Fu, K. F., and Lee, D. J. Validation of the RTOG recursive partitioning for head and neck tumors. Head Neck, 23: 669-677, 2001.
22. Werner-Wasik, M., Scott, C., Cox, J. D., Sause, W. T., Byhardt, R. W., Asbell, S., Russel, A., Komaki, R., and Lee, J. S. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int. J. Radiation Oncology Biol. Phys., 48: 1475-1482, 2000.
23. Hess, K. R., Abbruzzese, M. C., Lenzi, R., Raber, M. N., and Abbruzzese, J. L. Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma. Clin. Cancer Res., 5: 3403-3410, 1999.
24. Katz, A., Buchholz, T. A., Thomas, H., Smith, C. D., McNeese, M. D., Theriault, R., Singletary, S. E., and Strom, E. A. Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation. Int. J. Radiat. Oncol. Biol. Phys., 50: 397-403, 2001.
25. Freedman, G. M., Hanlan, A. L., Fawble, B. L., Anderson, P. R., and Nicolau, N. Recursive partitioning identifies patients at high risk and low risk for ipsilateral tumor recurrence after breast conserving surgery and radiation. J. Clin. Oncology, 20: 4014-4021, 2002.
26. Sackett, D. L., Haynes, R. B., Guyatt, G. H., and Tugwell, P. Clinical Epidemiology: A Basic Science for Clinical Medicine, Second Edition. Little, Brown and Company, Boston, 1991.
27. Ambrosini, G., Adida, C., and Altieri, D. C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med., 3: 917-992, 1997.
28. Bartek, J., and Lukas, J. Are all cancer genes equal? Nature (Lond.), 411: 1001-1002, 2001.
29. Boon, T., and van der Bruggen, P. Human tumor antigens recognized by T lymphocytes. J. Exp. Med., 183: 725-729, 1996.
30. Stockert, E., Jager, E., Chen, Y. T., Scanlan, M. J., Gout, I., Karbach, J., Arand, M., Knuth, A., and Old, L. J. A survey of humoral immune response of cancer patients to a panel of human tumor antigens. J. Exp. Med., 187: 1349-1354, 1998.